Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Ocular Therapeutix, Inc. (OCUL): A Bull Case Theory

We came across a bullish thesis on Ocular Therapeutix, Inc. on TipRanks’ YouTube channel. In this article, we will summarize the bulls’ thesis on OCUL. Ocular Therapeutix, Inc.'s share was trading at $10.43 as of January 13th.

[caption id="attachment_943655" align="aligncenter" width="750"] nrd-aMmDIsdnUro-unsplash[/caption]

Ocular Therapeutics (OCUL), currently trading at $13.24, has gained 62% over the past year and 13% in the last three months, reflecting strong investor confidence in its innovative ocular therapies. The company develops and commercializes treatments for...